Document:

Summary of Compensation for Non-employee Directors

 Exhibit 10.51 
 Arena Pharmaceuticals, Inc. 
 Non-employee Director
Compensation 
 Equity: 
  

	 	•	 	 New Directors: 18,000 options to purchase shares of our common stock. The options are 10-year options with an exercise price equal to the fair
market value of our common stock on the grant date, vesting in equal annual installments over two years. “Fair market value” on the grant date means the per share closing price of our common stock as reported on the NASDAQ Global Market on
the grant date or, if there was no reported closing price on such date, on the last preceding date on which the closing price was reported. 

  

	 	•	 	 Ongoing Directors: 12,000 options to purchase shares of our common stock. The options are 10-year options with an exercise price equal to the
fair market value of our common stock on the grant date, vesting in equal monthly installments over one year. 

 New director
grants are made on the 15th day of the month following the month of the director’s appointment or election to our Board of Directors and the annual grants are made to ongoing directors three trading days after our announcement of our prior
year’s financial results. For directors that did not serve for the full fiscal year preceding an annual grant, the grant is prorated based on the number of months such director served as a director in the prior year, if any. 
 Except in the case of a director’s death or disability, unvested stock options terminate when the director ceases to be a director. Unless earlier
terminated, vested stock options terminate three years after the director ceases to be a director (or, if applicable, an employee) for any reason other than the director’s death or disability. In the event of a director’s death or
disability, the director’s stock options become fully vested and exercisable and may be exercised within the earlier of three years after the date of the director’s death or disability, as applicable, or the end of the 10-year term of the
stock options. 
 Cash: 
  

	 	•	 	 Retainer: $20,000 annually, paid quarterly, subject to continuing service as a director. Prior to the beginning of any calendar year or, in the
case of a new director, to the extent permitted, prior to joining our Board of Directors, each director can irrevocably elect to take 25%, 50%, 75% or 100% of his or her retainer, or, in the case of a new director, his or her prorated retainer, in
stock options to purchase a number of shares of stock determined by dividing three times the retainer amount elected by the fair market value of our common stock on the grant date, rounded to the nearest whole share. Such options will be granted to
ongoing directors three trading days after our announcement of our prior year’s financial results and to new directors on the 15th day of the month following the month of the director’s appointment or election to our Board of Directors.
The options are 10-year options with an exercise price equal to the fair market value of our common stock on the grant date, vesting in approximately equal monthly installments over one year. Any portion of the retainer not converted into options
(as described above) will be paid on the applicable quarterly retainer payment dates. 

  

	 	    	If a director joins our Board of Directors after the first quarter of a calendar year, such directors’ retainer for that calendar year is reduced pro rata on a
quarterly basis. 

  

	 	•	 	 Meeting Attendance Fees: 

  

	 	•	 	 General: 

  

	 	•	 	 In-Person: $1,000 

  

	 	•	 	 Telephonic: $500 

	 	•	 	 Exceptions: 

  

	 	•	 	 Audit Chair Meeting Attendance Fee: 

  

	 	•	 	 In-Person: $3,000 

  

	 	•	 	 Telephonic: $1,500 

  

	 	•	 	 Other Chair Meeting Attendance Fee: 

  

	 	•	 	 In-Person: $2,000 

  

	 	•	 	 Telephonic: $1,000 

 In
addition, our Board of Directors and the Compensation Committee may authorize additional fees for significant work in informal meetings or for other service to us in the recipient’s capacity as a director or committee member. Each non-employee
director is also entitled to reimbursement for all of such director’s reasonable out-of-pocket expenses incurred in connection with performing Board business.Form of Restricted Agreement

 EXHIBIT 10.11 
 Dear                     : 
 We are pleased to inform you that on
                     (the “Grant Date”), pursuant to the Unigene Laboratories, Inc. 2006 Stock-Based Incentive Compensation Plan, as
amended (the “Plan”), the Compensation Committee of the Board of Directors (the “Committee”) of Unigene Laboratories, Inc. (the “Company”) granted you
             shares of the Company’s common stock, par value $0.01 (hereinafter either the “Restricted Stock” or “Award”), subject to the restrictions set
forth below. 
 This Award is subject to the applicable terms and conditions of the Plan, which are incorporated herein by
reference, and in the event of any contradiction, distinction or difference between this letter and the terms of the Plan, the terms of the Plan will control. Unless otherwise stated, all capitalized terms used herein have the meanings set forth in
the Plan. By accepting this Award you (i) acknowledge that you have received and read a copy of the Plan and understand its terms and (ii) acknowledge that with respect to this Award and the Restricted Stock, you are bound by the terms of
the Plan. 
 Subject to your continued employment with the Company, the restrictions applicable to your Restricted Stock will
lapse as to          of the Award on                     , the
             anniversary of the Grant Date. Prior to vesting, the Restricted Stock is not transferable, except, without consideration, to immediate family members (i.e., children,
grandchildren or spouse), to trusts for the benefit of such immediate family members and to partnerships in which such family members are the only partners. 
 Should your employment with the Company terminate for any reason (including by reason of death or disability) before any portion of your Award vests, then that portion of your Award shall be forfeited
with no further compensation due to you. Finally, if you are terminated by the Company for Cause, your entire Award, regardless of whether any or all of the shares of Restricted Stock that relate to such Award are vested, shall be forfeited and you
will be required to return all such shares (or the cash value) to the Company. 
 In the event that a Change in Control occurs
during your service with the Company, the Committee will determine at the time of such Change in Control if unvested portions of the Award will vest in full. 

 In conjunction with your acceptance of this Award, you agree to deliver a signed and undated
stock power to the Company or the Company’s designee authorizing the Committee to transfer title to the certificate(s) representing any shares of Restricted Stock that do not become vested. 
 When each portion of your Award vests, you must make appropriate arrangements with the Company to provide for the withholding of the taxes
that will be due with respect to this Award as it vests. As promptly thereafter as possible, the Company will issue to you, or if such certificates were previous issued, the Company will deliver to you, certificates for Common Stock in respect of
your vested Award, designating you as the registered owner. 
 The construction and interpretation of any provision of this
Award or the Plan shall be final and conclusive when made by the Committee. 
 Nothing in this letter shall confer on you the
right to continue in the service of the Company or interfere in any way with the right of the Company to terminate your service at any time. 
 You should sign and return a copy of this agreement to the Vice President of Finance indicating your agreement to the terms of this letter and the Award granted hereby. This acknowledgement must be
returned within fifteen (15) days; otherwise, the Award will lapse and become null and void. Your signature will also acknowledge that this letter reflects our final agreement regarding the Award granted hereunder and supersedes any prior
written or oral agreement, understanding or communication otherwise regarding your Award, and that you have received and reviewed the Plan and that you agree to abide by the applicable terms of these documents as provided herein. 
  

	
	 Very truly yours,

	
	  

 Enclosures

 The undersigned hereby agrees to the foregoing: 
  

					
		  	                    	  	                    
	 Name
	  	Date	  	

  

 - 2 -Assignment of Mortgage

 EXHIBIT 10.56 
 THIS DOCUMENT WAS PREPARED BY, 
 AND AFTER RECORDING, RETURN TO: 
 Sara Bucholtz 
 Dechert LLP 
 902 Carnegie Center, Suite 500 
 Princeton, NJ 08540-6531 
 Assignment of Mortgage 
 KNOW ALL MEN BY THESE PRESENTS, that in consideration of the sum of One Dollar ($1.00) and other valuable consideration, receipt of which is hereby acknowledged, and in connection with the assignment of
that certain promissory note dated September 30, 2008, between UNIGENE LABORATORIES, INC., a Delaware corporation authorized to do business in New Jersey (the “Company”), as Maker and JAY LEVY (“Assignor”), or
his registered assigns, as Holder, with an initial principal amount of Eight Million, Three Hundred Eighteen Thousand, Seven Hundred Fourteen and 00/100 Dollars ($8,318,714.00), Assignor hereby absolutely grants, assigns, conveys and transfers to
JEAN LEVY, or her successors or registered assigns (“Assignee”), all interest in that certain Mortgage and Security Agreement (“Mortgage”) dated July 13, 1999, recorded on August 27, 1999 in Book 7342 at
Page 254 of the Essex County Land Records from the Company to Assignor encumbering certain property located in the Township of Fairfield, County of Essex and State of New Jersey, as more particularly described in Exhibit A to the Mortgage;
Modification of Mortgage and Security Agreement dated August 5, 1999 recorded on October 28, 1999 in Book 428 at Page 264 of the Essex County Land Records; Modification of Mortgage and Security Agreement dated May 10, 2007 recorded on
August 9, 2007 in Book 12078 at Page 7355 of the Essex County Land Records; and Modification of Mortgage and Security Agreement dated September 30, 2008 recorded on October 27, 2008 in Book 12164 at Page 3367 of the Essex County Land
Records. 
 Together with the note therein described or referred to, the money due or to become due thereon with interest, and
all rights accrued or to accrue under said Mortgage and Security Agreement. 
 Except as otherwise set forth in the certain
Assignment and Assumption Agreement between Assignor and Assignee dated as of January 11, 2010, this Assignment is made without representation or warranty by, or recourse to, Assignor. 
 IN WITNESS WHEREOF, the undersigned has hereunto caused this instrument to be duly executed this 25th day of February, 2010. 
  

	
	 /s/ Jay Levy

	JAY LEVY
	

			
	STATE OF NEW JERSEY	 	    )
		 	    )  ss:
	COUNTY OF ESSEX	 	    )

 On this the 25th day of February, 2010 before me,
Linda L. Rohloff, the undersigned officer, personally appeared JAY LEVY to me personally known and known to me to be the same person whose name is signed to the foregoing instrument, and acknowledged the execution thereof for the uses and
purposes set forth. 
 In WITNESS WHEREOF I have hereunto set my hand and official seal. 
 Sworn and Subscribed to this 
 25th day of February, 2010 
  

	
	 /s/ Linda L. Rohloff

 Notary Information: 
 LINDA L. ROHLOFF 
 Notary Public, State of New Jersey 
 County of Passaic 
     Registration No. 2057307 
 Commission Expires April 11, 2014 

 Legal Description 
 110 Little Falls Road, Fairfield, NJ 
 All the real property
located in the Township of Fairfield, County of Essex, State of New Jersey and more particularly described as follows: 
 BEGINNING at a point
on the West side of Little Falls Road distant 805.68 feet northerly from the intersection of the West side of Little Falls Road and North side of Pier Lane; thence 
  

	(1)	Running through the lands formerly of Carrie DeVito, South 40 degrees 57 minutes, West 506.81 feet to a point; thence 

  

	(2)	Still through the lands of Carrie DeVito, North 89 degrees 09 minutes West, 59.13 feet to the West line of lands formerly of Carrie DeVito; thence

  

	(3)	Running along the West line of lands formerly of Carrie DeVito, North 6 degrees 19 minutes East, 352.04 feet to a pint; thence 

  

	(4)	Still along the West line of lands formerly of Carrie, DeVito, North 54 degrees 15 minutes East, 262.37 feet to the West side of Little Falls Road; thence

  

	(5)	Running along the West side of Little Falls Road, South 49 degrees 03 minutes East, 185.00 feet to the point and place of Beginning. 

 NOTE: Being Lot(s) 22, Block 2801, Tax Map of the Township of Fairfield, 
 BEING commonly known as 110 Little Falls Road, Fairfield, New Jersey. 
 BEING the same premises
conveyed to the Mortgagor herein by Deed recorded on June 23, 1982 in the Essex County Register’s Office in Book 4754, page 450.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}]]